Assignee
ESCAPE THERAPEUTICS INC
US·11 granted patents·7 pending applications·10 citations·filing 2012–2025
Top patents by PatentIndex Score
18 records- 0187US8822215B2Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the sameESCAPE THERAPEUTICS INC·Filed 2012·Granted Sep 2, 2014·4 cites·7 claims
- 0284US9347045B2Differentiation of mesenchymal stem cells into fibroblastsESCAPE THERAPEUTICS INC·Filed 2012·Granted May 24, 2016·5 cites·3 claims
- 0372US9714280B2HLA G-modified cells and methodsESCAPE THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·1 cites·12 claims
- 0470US2025288638A1Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitorsESCAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0569US9173904B2Method of cell transplantation into a human recipientESCAPE THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·0 cites·6 claims
- 0667US12415988B2Enhanced differentiation of mesenchymal stem cellsESCAPE THERAPEUTICS INC·Filed 2020·Granted Sep 16, 2025·0 cites·14 claims
- 0767US12251402B2Mesenchymal stem cells with enhanced immunosuppressive capabilityESCAPE THERAPEUTICS INC·Filed 2020·Granted Mar 18, 2025·0 cites·13 claims
- 0866US2018327718A1Enhanced differentiation of mesenchymal stem cellsESCAPE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0965US12414978B2Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitorsESCAPE THERAPEUTICS INC·Filed 2020·Granted Sep 16, 2025·0 cites·13 claims
- 1064US2015320865A1Hybrid hydrogel scaffold compositions and methods of useESCAPE THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1161US10053670B2Enhanced differentiation of mesenchymal stem cellsESCAPE THERAPEUTICS INC·Filed 2015·Granted Aug 21, 2018·0 cites·11 claims
- 1259US10576105B2Mesenchymal stem cells with enhanced immunosuppressive capabilityESCAPE THERAPEUTICS INC·Filed 2016·Granted Mar 3, 2020·0 cites·15 claims
- 1358US2023391825A1Enhanced skin permeation of a novel peptide via structural modification, chemical enhancement, and microneedlesESCAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1457US2016152953A1Endogenous expression of hla-g and/or hla-e by mesenchymal cellsESCAPE THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1555US2023100707A1Melanoma therapeuticsESCAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1653US9567368B2Peptide tyrosinase activatorsESCAPE THERAPEUTICS INC·Filed 2014·Granted Feb 14, 2017·0 cites·17 claims
- 1749US9554746B1System for evaluating skin treatmentESCAPE THERAPEUTICS INC·Filed 2014·Granted Jan 31, 2017·0 cites·19 claims
- 1836US2018296456A1Decapeptide-12 Modulation of Sirtuin Gene Expression in Epidermal Keratinocyte ProgenitorsESCAPE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →